---
title: "10X Genomics Purchase - Centre for Cardiovascular Science"
ocid: "ocds-r6ebe6-0000812046"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000812046"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000812046.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000812046.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "UNIVERSITY OF EDINBURGH"
published: "2025-10-03"
---

# 10X Genomics Purchase - Centre for Cardiovascular Science

Buyer: UNIVERSITY OF EDINBURGH  
Current stage: Award  
OCID: ocds-r6ebe6-0000812046

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000812046)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000812046.json)

## Summary

The University of Edinburgh has completed a procurement process for the purchase of reagents from 10X Genomics Inc. for the Centre for Cardiovascular Science. The procurement falls under the education industry category and the relevant location is Edinburgh, UK, specifically the University's facility within the Centre for Regenerative Medicine. The process was carried out using the 'limited' procurement method, specifically involving an award procedure without prior publication due to the exclusivity of 10X Genomics as the manufacturer. The contract was signed on 1st July 2025, with an active status and a total value of £98,285.50. This was a non-competitive tender stage as no other suppliers could provide the necessary goods due to technical reasons, as noted in the procurement rationale. The procurement is part of the Goods category and was covered by the GPA (Government Procurement Agreement). 

This procurement provides insight into opportunities specifically in technologically advanced and niche markets, where exclusivity can be a significant factor. Businesses involved in supplying highly specialised scientific equipment or materials may find similar opportunities for growth in collaborations with research-centric organisations like universities. Companies that are exclusive manufacturers or sole suppliers for unique and innovative products can benefit substantially from such non-competitive tenders, reinforcing the importance of maintaining technological leadership and uniqueness in product offerings to capture similar contracts.

## Notice

This non-competitive action is for the purchase of 10x Genomics' reagents for the 10x facility in the Centre for Regenerative Medicine. 10x Genomics is the exclusive manufacturer of the products and therefore the only supplier for this procurement.

### Lot Information

Lot 1

This non-competitive action is for the purchase of 10x Genomics' reagents for the 10x facility in the Centre for Regenerative Medicine. 10x Genomics is the exclusive manufacturer of the products and therefore the only supplier for this procurement.

### Procurement Information

This non-competitive action is forthe purchase of 10x Genomics' reagents for the 10x facility in the Centre for Regenerative Medicine. 10x Genomics is the exclusive manufacturer of the products and therefore the only supplier for this procurement. As a consequence, it is not possible to procure these items from any other source than 10x Genomics.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT540628 |
| Notice type | PCS Notice - Website Contract Award Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 3 Oct 2025 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 1 Jul 2025 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £98,285 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | UNIVERSITY OF EDINBURGH |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH1 1HT |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | City Centre |
| Westminster constituency | Edinburgh East and Musselburgh |
| Delivery location | TLM75 City of Edinburgh |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | 10X GENOMICS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33696500 - Laboratory reagents

## Release History

- 3 Oct 2025 at 00:00 - Award - PCS Notice - Website Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT540628

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=OCT540628
  10X Genomics Purchase - Centre for Cardiovascular Science - This non-competitive action is for the purchase of 10x Genomics' reagents for the 10x facility in the Centre for Regenerative Medicine. 10x Genomics is the exclusive manufacturer of the products and therefore the only supplier for this procurement.

## Notice URLs

- http://
- http://www.ed.ac.uk
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000812046

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000812046. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000812046.json.